NCT07176104View on ClinicalTrials.gov

Functional Milk Supplementation to Reduce In-Stent Restenosis in STEMI Patients (SMASOEA Trial)

NANot yet recruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

August 31, 2027

Conditions
ST-elevation Myocardial Infarction (STEMI)In-stent Restenosis
Interventions
DIETARY_SUPPLEMENT

Functional Bovine Milk

Functional milk product enriched with standardised bioactive peptides, provided daily for 12 months.

DIETARY_SUPPLEMENT

Non-Functional Bovine Milk

Standard bovine milk with identical caloric and macronutrient profile to the functionalized milk, without enrichment, provided daily for 12 months.

Trial Locations (1)

80138

"Università degli Studi della Campania Luigi Vanvitelli - Dipartimento di Scienze Mediche e Chirurgiche Avanzate", Napoli

All Listed Sponsors
collaborator

Ministry of Health, Italy

OTHER_GOV

lead

Raffaele Marfella

OTHER

NCT07176104 - Functional Milk Supplementation to Reduce In-Stent Restenosis in STEMI Patients (SMASOEA Trial) | Biotech Hunter | Biotech Hunter